Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Amy Dyken, controller at Sweet Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related

Amy Dyken, controller at Sweet Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Sweets financial statements. Below is selected financial information for the fiscal year ended June 30, 2017.

SWEET PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2017

Long-term debt
Notes payable, 11%

$990,000

7% convertible bonds payable

5,080,000

11% bonds payable

6,120,000

Total long-term debt

$12,190,000

Shareholders equity
Preferred stock, 6% cumulative, $50 par value, 95,000 shares authorized, 23,750 shares issued and outstanding

$1,187,500

Common stock, $1 par, 10,000,000 shares authorized, 1,000,000 shares issued and outstanding

1,000,000

Additional paid-in capital

3,920,000

Retained earnings

5,880,000

Total shareholders equity

$11,987,500

The following transactions have also occurred at Sweet.

1. Options were granted on July 1, 2016, to purchase 180,000 shares at $15 per share. Although no options were exercised during fiscal year 2017, the average price per common share during fiscal year 2017 was $20 per share.
2. Each bond was issued at face value. The 7% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2016.
3. The preferred stock was issued in 2016.
4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2017.
5. The 1,000,000 shares of common stock were outstanding for the entire 2017 fiscal year.
6. Net income for fiscal year 2017 was $1,500,000, and the average income tax rate is 40%.

For the fiscal year ended June 30, 2017, calculate the following for Sweet Pharmaceutical Industries.

1) Basic Earnings Per Share

2) Diluted Earnings Per Share

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

The Essential Handbook Of Internal Auditing

Authors: K. H. Spencer Pickett

1st Edition

0470013168, 978-0470013168

More Books

Students also viewed these Accounting questions

Question

=+ (a) Show that C is uncountable but trifling.

Answered: 1 week ago